Prevalence, Mortality and Healthcare Utilization Among Medicare Beneficiaries with Hepatitis C in Haemodialysis Units
Deshpande R, Stepanova M, Golabi P, Brown K, and Younossi ZM. Prevalence, Mortality and Healthcare Utilization Among Medicare Beneficiaries with Hepatitis C in Hemodialysis Units. J Viral Hepat 2019.
Journal of viral hepatitis
Hepatitis C (HCV) is more common among patients with end-stage renal disease requiring haemodialysis compared to the general population. Thus, we aimed to assess trends in prevalence, health resource utilization and mortality among Medicare beneficiaries with HCV on haemodialysis. This is a retrospective study of outpatient and inpatient claims for Medicare beneficiaries receiving haemodialysis (2005-2016). A total of 291 663 subjects on haemodialysis were included (67.3 ± 15.2 years, 55% male, 55% white, 49% age-based eligibility). The prevalence of HCV in subjects on haemodialysis was stable and was significantly higher (mean 4.2% in 2005-2016, P = 0.50 for the trend) than in subjects not on haemodialysis (
ePub ahead of print